Invention Grant
US07993658B2 Targeting of triacylclycerol synthase gene for tuberculosis treatment
有权
三酰基甘油合成酶基因靶向治疗结核病
- Patent Title: Targeting of triacylclycerol synthase gene for tuberculosis treatment
- Patent Title (中): 三酰基甘油合成酶基因靶向治疗结核病
-
Application No.: US12546368Application Date: 2009-08-24
-
Publication No.: US07993658B2Publication Date: 2011-08-09
- Inventor: Pappachan E. Kolattukudy , Tatiana Sirakova , Vinod S. Dubey , Jaiyanth Daniel
- Applicant: Pappachan E. Kolattukudy , Tatiana Sirakova , Vinod S. Dubey , Jaiyanth Daniel
- Applicant Address: US FL Orlando
- Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee Address: US FL Orlando
- Agency: Beusse, Wolter, Sanks, Mora & Maire, P.A.
- Agent Timothy H. Van Dyke
- Main IPC: A61K39/04
- IPC: A61K39/04 ; A61K39/02 ; A61K39/00
Abstract:
Disclosed herein are novel methods for screening for compounds useful in treating or preventing tuberculosis. In exemplary embodiments, screening methods are based on the implementation or manipulation of triacylglycerol synthase like polypeptides or polynucleotides encoding the same. The methods are useful in identifying agents active against TB infection.
Public/Granted literature
- US20100021453A1 TARGETING OF TRIACYLCLYCEROL SYNTHASE GENE FOR TUBERCULOSIS TREATMENT Public/Granted day:2010-01-28
Information query
